Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thrombin Inhibition Preoperatively in Early Breast Cancer
2014-004909-33Phase 2Unknown
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of rivaroxaban in breast cancer (3 arms), sponsored by Manchester University NHS Foundation Trust. Status: unknown.
02
Drugs
rivaroxaban
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2014-004909-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004909-33.